U.S. FDA declines to approve Orexo’s opioid overdose drug
The U.S. Food and Drug Administration (FDA) has declined to approve Orexo AB’s high-dose prescription drug for opioid overdose, the company said on Tuesday. The health regulator, in a so-called complete response letter, has sought an additional Human…